Kadmon Announces Expanded Results of Interim Analysis of Pivotal Trial of KD025 in cGVHD – Benzinga
By daniellenierenberg
Patient Analyses and Safety Data Continue to Underscore Positive Impact of KD025 in cGVHD
Pre-NDA Meeting with FDA Planned for March 2020; Topline Results of Primary Analysis to be Announced in Q2 2020
NEW YORK, NY / ACCESSWIRE / February 23, 2020 / Kadmon Holdings, Inc. (NYSE:KDMN) today announced expanded results from the previously reported interim analysis of ROCKstar (KD025-213), its ongoing pivotal trial of KD025 in chronic graft-versus-host disease (cGVHD). The data were presented today in the oral latebreaker session at the 2020 Transplantation & Cellular Therapy (TCT) Meetings.
As announced in November 2019, KD025 met the primary endpoint of Overall Response Rate (ORR) at the study's planned interim analysis, two months after completion of enrollment. KD025 showed statistically significant and clinically meaningful ORRs of 64% with KD025 200 mg once daily (95% Confidence Interval (CI): 51%, 75%; p<0.0001) and 67% with KD025 200 mg twice daily (95% CI: 54%, 78%; p<0.0001). In the expanded KD025-213 dataset presented today, ORRs were consistent with the previously reported interim analysis across key subgroups, including in patients with four or more organs affected by cGVHD (n=69; 64%), patients who had prior treatment with ibrutinib (n=45; 62%) and patients who had prior treatment with ruxolitinib (n=37; 62%). Three patients achieved a Complete Response. Responses were observed in all affected organ systems, including in organs with fibrotic disease. KD025 has been well tolerated: adverse events were consistent overall with those expected to be observed in cGVHD patients receiving corticosteroids, and no apparent increased risk of infection was observed. Additional secondary endpoints, including duration of response, corticosteroid dose reductions, Failure-Free Survival, Overall Survival and Lee Symptom Scale reductions continue to mature and will be available later in 2020.
"KD025 has been well tolerated and has already demonstrated high response rates in patients with severe and complex cGVHD after a median of five months of follow-up," said Corey Cutler, MD, MPH, FRCPC, Associate Professor of Medicine, Harvard Medical School; Medical Director, Adult Stem Cell Transplantation Program, Dana-Farber Cancer Institute and a KD025-213 study investigator and Steering Committee member.
"We are extremely pleased with the interim outcomes of this pivotal trial of KD025 in cGVHD, which track closely our findings from our earlier Phase 2 study. KD025 achieved robust response rates across all subgroups of this difficult-to-treat patient population, who had a median of four prior lines of therapy, and 73% of whom had no response to their last line of treatment," said Harlan W. Waksal, M.D., President and CEO of Kadmon. "We plan to meet with the FDA for a pre-NDA meeting in March 2020 and to announce topline results from the primary analysis of this trial in Q2 2020."
At the TCT Meetings, Kadmon also presented long-term follow-up data from KD025-208, its ongoing Phase 2 study of KD025 in cGVHD (Abstract #15205). These data were recently presented at the 61st American Society of Hematology (ASH) Annual Meeting and Exposition in December 2019.
About the ROCKstar (KD025-213) Trial
KD025-213 is an ongoing open-label trial of KD025 in adults and adolescents with cGVHD who have received at least two prior lines of systemic therapy. Patients were randomized to receive KD025 200 mg once daily or KD025 200 mg twice daily, enrolling 66 patients per arm. Statistical significance is achieved if the lower bound of the 95% CI of ORR exceeds 30%.
While the ORR endpoint was met at the interim analysis, which was conducted as scheduled two months after completion of enrollment, topline data from the primary analysis of the KD025-213 study, six months after completion of enrollment, will be reported in Q2 2020. Full data from the primary analysis will be submitted for presentation at an upcoming scientific meeting.
About KD025
KD025 is a selective oral inhibitor of Rho-associated coiled-coil kinase 2 (ROCK2), a signaling pathway that modulates immune response as well as fibrotic pathways. In addition to cGVHD, KD025 is being studied in an ongoing Phase 2 clinical trial in adults with diffuse cutaneous systemic sclerosis (KD025-209). KD025 was granted Breakthrough Therapy Designation and Orphan Drug Designation by the U.S. Food and Drug Administration for the treatment of patients with cGVHD who have received at least two prior lines of systemic therapy.
About cGVHD
cGVHD is a common and often fatal complication following hematopoietic stem cell transplantation. In cGVHD, transplanted immune cells (graft) attack the patient's cells (host), leading to inflammation and fibrosis in multiple tissues, including skin, mouth, eye, joints, liver, lung, esophagus and gastrointestinal tract. Approximately 14,000 patients in the United States are currently living with cGVHD, and approximately 5,000 new patients are diagnosed with cGVHD per year.
About Kadmon
Kadmon is a clinical-stage biopharmaceutical company that discovers, develops and delivers transformative therapies for unmet medical needs. Our clinical pipeline includes treatments for immune and fibrotic diseases as well as immuno-oncology therapies.
Forward Looking Statements
This press release contains forward-looking statements. Such statements may be preceded by the words "may," "will," "should," "expects," "plans," "anticipates," "could," "intends," "targets," "projects," "contemplates," "believes," "estimates," "predicts," "potential" or "continue" or the negative of these terms or other similar expressions. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. We believe that these factors include, but are not limited to, (i) the initiation, timing, progress and results of our preclinical studies and clinical trials, and our research and development programs; (ii) our ability to advance product candidates into, and successfully complete, clinical trials; (iii) our reliance on the success of our product candidates; (iv) the timing or likelihood of regulatory filings and approvals; (v) our ability to expand our sales and marketing capabilities; (vi) the commercialization of our product candidates, if approved; (vii) the pricing and reimbursement of our product candidates, if approved; (viii) the implementation of our business model, strategic plans for our business, product candidates and technology; (ix) the scope of protection we are able to establish and maintain for intellectual property rights covering our product candidates and technology; (x) our ability to operate our business without infringing the intellectual property rights and proprietary technology of third parties; (xi) costs associated with defending intellectual property infringement, product liability and other claims; (xii) regulatory developments in the United States, Europe, China, Japan and other jurisdictions; (xiii) estimates of our expenses, future revenues, capital requirements and our needs for additional financing; (xiv) the potential benefits of strategic collaboration agreements and our ability to enter into strategic arrangements; (xv) our ability to maintain and establish collaborations or obtain additional grant funding; (xvi) the rate and degree of market acceptance of our product candidates; (xvii) developments relating to our competitors and our industry, including competing therapies; (xviii) our ability to effectively manage our anticipated growth; (xix) our ability to attract and retain qualified employees and key personnel (xx) the potential benefits from any of our product candidates being granted orphan drug or breakthrough designation; (xxi) the future trading price of the shares of our common stock and impact of securities analysts' reports on these prices; and/or (xxii) other risks and uncertainties. More detailed information about Kadmon and the risk factors that may affect the realization of forward-looking statements is set forth in the Company's filings with the U.S. Securities and Exchange Commission (the "SEC"), including the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2018 and subsequent Quarterly Reports on Form 10-Q. Investors and security holders are urged to read these documents free of charge on the SEC's website at http://www.sec.gov. The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise.
Contact Information
Ellen Cavaleri, Investor Relations646.490.2989ellen.cavaleri@kadmon.com
SOURCE: Kadmon Holdings, Inc.
View source version on accesswire.com: https://www.accesswire.com/577466/Kadmon-Announces-Expanded-Results-of-Interim-Analysis-of-Pivotal-Trial-of-KD025-in-cGVHD
Link:
Kadmon Announces Expanded Results of Interim Analysis of Pivotal Trial of KD025 in cGVHD - Benzinga
- 001 Elaine Fuchs discusses research on skin and adult stem cells [Last Updated On: June 25th, 2011] [Originally Added On: June 25th, 2011]
- 002 Skin Stem Cells: Their Biology [Last Updated On: June 25th, 2011] [Originally Added On: June 25th, 2011]
- 003 Come Back Kid [Last Updated On: June 26th, 2011] [Originally Added On: June 26th, 2011]
- 004 Emerge Labs New Anti Aging Swiss Apple Stem Cell Skin Care [Last Updated On: June 26th, 2011] [Originally Added On: June 26th, 2011]
- 005 PhytoCell.mp4 [Last Updated On: June 26th, 2011] [Originally Added On: June 26th, 2011]
- 006 Elaine Fuchs Part 2: Tapping the Potential of Adult Stem Cells, and Summary [Last Updated On: June 28th, 2011] [Originally Added On: June 28th, 2011]
- 007 Elaine Fuchs Part 1: Introduction to Stem Cells [Last Updated On: July 1st, 2011] [Originally Added On: July 1st, 2011]
- 008 Stem Cell Facial At Metamorphosis Day Spa Using Emerge Labs Skin Care [Last Updated On: July 1st, 2011] [Originally Added On: July 1st, 2011]
- 009 A Major Breakthrough in Skin Care and Nutrition [Last Updated On: July 7th, 2011] [Originally Added On: July 7th, 2011]
- 010 The Skin Gun stem cell research [Last Updated On: July 7th, 2011] [Originally Added On: July 7th, 2011]
- 011 The Skin Gun [Last Updated On: July 7th, 2011] [Originally Added On: July 7th, 2011]
- 012 E'shee HBA Global Expo 2011, NYC. Skin Care Anti-Aging Symposium [Last Updated On: July 8th, 2011] [Originally Added On: July 8th, 2011]
- 013 World's 1st Nutricosmetic with Stem Cell Nutrients [Last Updated On: July 15th, 2011] [Originally Added On: July 15th, 2011]
- 014 Stem cells acquired from human skin [Last Updated On: August 22nd, 2011] [Originally Added On: August 22nd, 2011]
- 015 DermaStem Renewal Serum - Stem Cells for Your Skin from STEMTech - New Paradigm in Beauty! [Last Updated On: August 30th, 2011] [Originally Added On: August 30th, 2011]
- 016 Stem Cells Made From Human Skin [Last Updated On: September 4th, 2011] [Originally Added On: September 4th, 2011]
- 017 ReLuma-stemcells- skin rejuvenation [Last Updated On: September 5th, 2011] [Originally Added On: September 5th, 2011]
- 018 Jeunesse Global Business Opportunity with Stem Cell Skin Care Developed by Dr Nathan Newman [Last Updated On: September 5th, 2011] [Originally Added On: September 5th, 2011]
- 019 Dr Nathan Newman- Formulator of Stem Cell Skin Care Line LUMINESCE [Last Updated On: September 6th, 2011] [Originally Added On: September 6th, 2011]
- 020 Luminesce Stem Cell Skin Care - Leaders in Jeunesse [Last Updated On: September 7th, 2011] [Originally Added On: September 7th, 2011]
- 021 Stem Cell Therapy - BioLogic Anti-Aging Skin Cream [Last Updated On: September 7th, 2011] [Originally Added On: September 7th, 2011]
- 022 Isolation and Culture of Adult Epithelial Stem Cells from Human Skin [Last Updated On: September 8th, 2011] [Originally Added On: September 8th, 2011]
- 023 Stem Cell Skin Care- What is the role of stem cells in Luminesce Featuring Dr Nathan Newman [Last Updated On: September 9th, 2011] [Originally Added On: September 9th, 2011]
- 024 Genetic Skin Disease (EB): Spotlight on Stem Cell Research - Patient Advocate [Last Updated On: September 11th, 2011] [Originally Added On: September 11th, 2011]
- 025 Genetic Skin Disease (EB): Optimizing Embryonic Stem Cell Differentiation Protocols [Last Updated On: September 12th, 2011] [Originally Added On: September 12th, 2011]
- 026 Genetic Skin Disease (EB): Spotlight on Stem Cell Research - Introduction [Last Updated On: September 13th, 2011] [Originally Added On: September 13th, 2011]
- 027 The Skin Gun (Stem Cell research to replace burnt off skin. Done in 3 days!) [Last Updated On: September 15th, 2011] [Originally Added On: September 15th, 2011]
- 028 Best natural skin care serum using stem cell technology [Last Updated On: September 22nd, 2011] [Originally Added On: September 22nd, 2011]
- 029 Stem Cells: Fulfilling the Promise - 2011 CIRM Grantee Meeting [Last Updated On: September 24th, 2011] [Originally Added On: September 24th, 2011]
- 030 Jeunesse Global Opportunity- Stem Cell Skin Care [Last Updated On: September 25th, 2011] [Originally Added On: September 25th, 2011]
- 031 Research on skin cancer: ERC funds studies on stem cells [Last Updated On: September 26th, 2011] [Originally Added On: September 26th, 2011]
- 032 Stem Cell Therapy Skin Repair and Anti-Wrinkle Cream [Last Updated On: September 29th, 2011] [Originally Added On: September 29th, 2011]
- 033 Skin engineering [Last Updated On: September 30th, 2011] [Originally Added On: September 30th, 2011]
- 034 Stem Cell Face Treatment - What People Are Saying | Beverly Hills | Los Angeles [Last Updated On: October 1st, 2011] [Originally Added On: October 1st, 2011]
- 035 How To Use Your Stem Cells For Facial Skin Rejuvenation [Last Updated On: October 5th, 2011] [Originally Added On: October 5th, 2011]
- 036 AMAZING - Stem Cell Skin Cream And Liquid Face Lift Revealed [Last Updated On: October 5th, 2011] [Originally Added On: October 5th, 2011]
- 037 Dr Nathan Newman MD Stem Cell Face lift on Channel 7 KABC.flv [Last Updated On: October 5th, 2011] [Originally Added On: October 5th, 2011]
- 038 Genetic Skin Disease (EB): Spotlight on Stem Cell Research - Welcome [Last Updated On: October 5th, 2011] [Originally Added On: October 5th, 2011]
- 039 Dr.Thomas Barnes' PRP Hair Growth and Skin Rejuvenation [Last Updated On: October 5th, 2011] [Originally Added On: October 5th, 2011]
- 040 For Damaged Skin - Rejuvenate Your Own Stem Cells [Last Updated On: October 5th, 2011] [Originally Added On: October 5th, 2011]
- 041 real food real life - Stemulance stem cell face products [Last Updated On: October 5th, 2011] [Originally Added On: October 5th, 2011]
- 042 Dr Amiya Prasad discusses ACell for Hair Regrowth and Skin Rejuvenation with EYES IN Magazine [Last Updated On: October 5th, 2011] [Originally Added On: October 5th, 2011]
- 043 Stem Cell Face Lift - English (Part 5) [Last Updated On: October 6th, 2011] [Originally Added On: October 6th, 2011]
- 044 Cell Reprogramming Transformed [Last Updated On: October 6th, 2011] [Originally Added On: October 6th, 2011]
- 045 Care for Your Skin with Lifeline Skin Care [Last Updated On: October 6th, 2011] [Originally Added On: October 6th, 2011]
- 046 Dr Nathan Newman Repairs Laugh Lines With Stem Cell Face Lift [Last Updated On: October 6th, 2011] [Originally Added On: October 6th, 2011]
- 047 Ellis Martin Report with International Stem Cell Corp [Last Updated On: October 6th, 2011] [Originally Added On: October 6th, 2011]
- 048 Stem Cell Banking: The Perspective of an iPS Donor Family [Last Updated On: October 6th, 2011] [Originally Added On: October 6th, 2011]
- 049 Dr Nathan Newman Stem Cell Face Lift on Entertainment Tonight [Last Updated On: October 8th, 2011] [Originally Added On: October 8th, 2011]
- 050 Elaine Fuchs Part 1: Introduction to Stem Cells English Subtitle [Last Updated On: October 12th, 2011] [Originally Added On: October 12th, 2011]
- 051 Signals Stem Cell Skin Care Anti Aging Skin Care - Video [Last Updated On: October 14th, 2011] [Originally Added On: October 14th, 2011]
- 052 Stem Cell Skin Care - Born Different.mp4 - Video [Last Updated On: October 18th, 2011] [Originally Added On: October 18th, 2011]
- 053 APPLE STEMCELL by SEMCELL - Video [Last Updated On: October 21st, 2011] [Originally Added On: October 21st, 2011]
- 054 Jeunesse Luminesce Stem Cell Skin care Before and After Pictures - Video [Last Updated On: October 23rd, 2011] [Originally Added On: October 23rd, 2011]
- 055 Stem Cell Therapy -- Reduce Wrinkles,Promote Younger, Healthier Looking Skin - Video [Last Updated On: October 25th, 2011] [Originally Added On: October 25th, 2011]
- 056 Scientists Create Liver from Reprogrammed Human Skin Cells No Stem Cells Needed - Video [Last Updated On: October 25th, 2011] [Originally Added On: October 25th, 2011]
- 057 Vitiligo and Stem Cells: Narrowband UVB Phototherapy in Nonsegmental Vitiligo - Video [Last Updated On: October 25th, 2011] [Originally Added On: October 25th, 2011]
- 058 Dr Nathan Newman MD Stem Cell Face lift on Entertainment Tonight - NewHopeForAging.com - Video [Last Updated On: October 25th, 2011] [Originally Added On: October 25th, 2011]
- 059 Skin Healing And Anti-Aging - Rejuvenate Aging Skin Cells - Video [Last Updated On: October 25th, 2011] [Originally Added On: October 25th, 2011]
- 060 Stem Cell Face Lift - Video [Last Updated On: October 27th, 2011] [Originally Added On: October 27th, 2011]
- 061 Stem Cell Therapy Face Cream - Video [Last Updated On: October 27th, 2011] [Originally Added On: October 27th, 2011]
- 062 Growing skin in lab with stem cells Video Reuters - Video [Last Updated On: October 27th, 2011] [Originally Added On: October 27th, 2011]
- 063 Stem Cells and Their Lineages in Skin - Video [Last Updated On: October 27th, 2011] [Originally Added On: October 27th, 2011]
- 064 Stem Cells Rock - Video [Last Updated On: October 27th, 2011] [Originally Added On: October 27th, 2011]
- 065 Stem Cell Therapy: Healing Force of the future - Video [Last Updated On: October 29th, 2011] [Originally Added On: October 29th, 2011]
- 066 Alex Cosmeceuticals - Phyto Stem Cell Technology - Video [Last Updated On: October 29th, 2011] [Originally Added On: October 29th, 2011]
- 067 Reprogramming skin cells into embryonic stem cells - Video [Last Updated On: October 29th, 2011] [Originally Added On: October 29th, 2011]
- 068 Ellis Martin Report with International Stem Cell Corp - YouTube2.flv - Video [Last Updated On: October 30th, 2011] [Originally Added On: October 30th, 2011]
- 069 Dr Lyras Plastic Surgery - Skin Needling 3 - Tv 2011 - Video [Last Updated On: November 5th, 2011] [Originally Added On: November 5th, 2011]
- 070 Donna Queen-Lifeline Skin Care at the CACS - Video [Last Updated On: November 8th, 2011] [Originally Added On: November 8th, 2011]
- 071 Turning Science Into Action with Heather Livingston - Part 1 www.miraclecell.info - Video [Last Updated On: November 12th, 2011] [Originally Added On: November 12th, 2011]
- 072 US scientists unveil new cloning method for embryonic stem cells - Video [Last Updated On: November 12th, 2011] [Originally Added On: November 12th, 2011]
- 073 A Stem Cell Story - Video [Last Updated On: November 12th, 2011] [Originally Added On: November 12th, 2011]
- 074 Perspectives of a Stem Cell Donor Family - Video [Last Updated On: November 13th, 2011] [Originally Added On: November 13th, 2011]
- 075 Adult Stem Cell Success Stories - Amy Daniels - Video [Last Updated On: November 15th, 2011] [Originally Added On: November 15th, 2011]
- 076 StemCellTV - From National Geographic - The Skin Gun - Healing Burns with Stem Cells - Video [Last Updated On: November 16th, 2011] [Originally Added On: November 16th, 2011]
- 077 Stem Cell Skin Care Jeunesse- Dr Newman FAQ - Video [Last Updated On: November 18th, 2011] [Originally Added On: November 18th, 2011]
- 078 Dr Nathan Newman and Jeunesse Stem Cell Skin Care - Video [Last Updated On: November 26th, 2011] [Originally Added On: November 26th, 2011]
- 079 Apple Stem Cell-Skin aging solution - Video [Last Updated On: November 29th, 2011] [Originally Added On: November 29th, 2011]
- 080 Luminesce rejuvenation serum cellular rejuvenation stem cell skin Products - Video [Last Updated On: November 29th, 2011] [Originally Added On: November 29th, 2011]
